Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Hello Group to Report Second Quarter 2022 Results on September 1, 2022 2022-08-19 19:00
World's First CAR-T for NMOSD Treatment, IASO Biotherapeutics' Equecabtagene Autoleucel, Receives IND Approval by NMPA 2022-08-19 18:41
AiDot launches 18-month Cloud Service Package with Data Analysis 2022-08-19 18:30
Regional Brand Identity of Hinggan League Officially Released 2022-08-19 18:26
Camel Group's Practice of ESG Concept Receives High Commendation from International Expert Team 2022-08-19 18:16
China-led world conference on vocational, technical education to open in Tianjin 2022-08-19 18:07
Ucommune Announces Adjournment of Extraordinary General Meeting 2022-08-19 18:00
Kuke Reports Second Quarter 2022 Unaudited Financial Results 2022-08-19 17:43
Vipshop Reports Unaudited Second Quarter 2022 Financial Results 2022-08-19 17:00
COUNTDOWN TO ITE HCMC 2022 - WHERE TOURISM INDUSTRY "GROWING FORWARD TOGETHER" 2022-08-19 16:51
J INTS BIO successfully held its 1st International Advisory Board Meeting for its Novel Oral 4th Generation EGFR TKI (JIN-A02) in Vienna, Austria during WCLC 2022-08-19 16:00
Nuance Pharma Announces Clearance of IND Application for Ensifentrine Pivotal Clinical Trials for COPD in China 2022-08-19 11:24
BLUETTI will have a Power Week from August 18 to August 28 2022-08-19 11:08
FF Top, A Major Stockholder of Faraday Future, Files Preliminary Proxy Statement for Special Meeting: Stockholders to Vote on the Removal of Director Brian Krolicki 2022-08-19 10:35
BLUETTI To Have Power Week From August 18 to August 28 2022-08-19 10:00
First World Vocational and Technical Education Development Conference held in north China's Tianjin 2022-08-19 08:00
9F Inc. Announces Receipt of Minimum Bid Price Notice from Nasdaq 2022-08-19 04:05
First launch! Breaking through the limits of traditional diagnostics, MUCAR CDE900. 2022-08-19 03:00
Amorepacific Develops World's First Chip-less Wireless Electronic Skin Enabled by Semiconductors 2022-08-19 02:00
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ 2022-08-18 23:46
1 573 574 575 576 577 6438